Marimed (MRMD) Change in Account Payables (2011 - 2026)
Marimed (MRMD) posted quarterly Change in Account Payables of $523000.0 for Q1 2026, up 508.14% year-over-year from $86000.0 in Q1 2025, and down 85.19% quarter-over-quarter from $3.5 million in Q4 2025.
Marimed (MRMD) Change in Account Payables (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Change in Account Payables for 16 consecutive years, with $523000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 508.14% year-over-year to $523000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 56.53% YoY), while the FY2025 annual figure was $841000.0, down 79.92% from the prior year.
- Change in Account Payables declined to $523000.0 in Q1 2026 per MRMD's latest filing, from $3.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.5 million in Q4 2025 and bottomed at -$2.8 million in Q2 2025.
- Historically, Change in Account Payables has averaged $526705.9 across 5 years, with a median of $507000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 278.92% — and 2025, when it surged 11134.38%.
- Marimed's Change in Account Payables stood at -$1.3 million in 2022, then soared by 137.7% to $507000.0 in 2023, then plunged by 106.31% to -$32000.0 in 2024, then soared by 11134.38% to $3.5 million in 2025, then slumped by 85.19% to $523000.0 in 2026.
- Business Quant data shows MRMD's Change in Account Payables at $523000.0 in Q1 2026, $3.5 million in Q4 2025, and $23000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Marimed | 28.77 Mn | 20.33 Mn | 16.23 Mn | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.96 Mn |
| Jun 30, 2026 | -1.96 Mn |
| Mar 31, 2026 | 523,000.00 |
| Mar 31, 2026 | 523,000.00 |
| Dec 31, 2025 | 3.53 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -2.80 Mn |
| Jun 30, 2025 | -2.80 Mn |
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Jun 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |